Short description
Focus-X Therapeutics is a preclinical-stage biotechnology company focused on the radiopharmaceutical pipeline.
Description
Focus-X Therapeutics is a preclinical-stage biotechnology company focused on the radiopharmaceutical pipeline. They focus on unmet needs in cancer diagnosis and therapy by applying our theragnostic approach to solid tumors with a very low five-year survival rate. It brings its proprietary radioligand therapy (RLT) to precisely deliver alpha or beta emitters to break down cancer cell DNA.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Sammamish, Washington, United States, North America
Founded on
August 14, 2020
Exited on
November 28, 2022
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Uh Ohhhh, Nopepepe
Sign in for full access
Founders
Fa Liu, Hui Qi